These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10579797)

  • 1. Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines.
    Jongsma J; Oomen MH; Noordzij MA; Romijn JC; van Der Kwast TH; Schröder FH; van Steenbrugge GJ
    Prostate; 2000 Jan; 42(1):34-44. PubMed ID: 10579797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity.
    van Steenbrugge GJ; van Uffelen CJ; Bolt J; Schröder FH
    J Steroid Biochem Mol Biol; 1991; 40(1-3):207-14. PubMed ID: 1958522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells.
    Aprikian AG; Han K; Chevalier S; Bazinet M; Viallet J
    J Mol Endocrinol; 1996 Jun; 16(3):297-306. PubMed ID: 8782088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells.
    Reile H; Armatis PE; Schally AV
    Prostate; 1994 Jul; 25(1):29-38. PubMed ID: 8022709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of the neuropeptides bombesin and calcitonin on the growth of prostate cell lines, PC-3, DU 145, and LNCaP].
    Larrán López J; Aparicio Patino J; López Muñoz A; Vilches Troya J
    Actas Urol Esp; 2000; 24(10):779-84. PubMed ID: 11199293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different profiles of neuroendocrine cell differentiation evolve in the PC-310 human prostate cancer model during long-term androgen deprivation.
    Jongsma J; Oomen MH; Noordzij MA; Van Weerden WM; Martens GJ; van der Kwast TH; Schröder FH; van Steenbrugge GJ
    Prostate; 2002 Mar; 50(4):203-15. PubMed ID: 11870798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells.
    Lu S; Tsai SY; Tsai MJ
    Endocrinology; 1999 Nov; 140(11):5054-9. PubMed ID: 10537131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
    Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M
    Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
    Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response.
    Soto AM; Lin TM; Sakabe K; Olea N; Damassa DA; Sonnenschein C
    Oncol Res; 1995; 7(10-11):545-58. PubMed ID: 8866667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer.
    Yang JC; Ok JH; Busby JE; Borowsky AD; Kung HJ; Evans CP
    Cancer Res; 2009 Jan; 69(1):151-60. PubMed ID: 19117998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation.
    Jongsma J; Oomen MH; Noordzij MA; Van Weerden WM; Martens GJ; van der Kwast TH; Schröder FH; van Steenbrugge GJ
    Cancer Res; 2000 Feb; 60(3):741-8. PubMed ID: 10676662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
    Siu SW; Lau KW; Tam PC; Shiu SY
    Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y; Wolff DW; Lin MF; Tu Y
    Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.
    Lee LF; Guan J; Qiu Y; Kung HJ
    Mol Cell Biol; 2001 Dec; 21(24):8385-97. PubMed ID: 11713275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of neuroendocrine differentiation on the growth and androgen receptor expression of prostate carcinoma cells].
    Song Y; Wu G; Xin DQ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(23):1453-6. PubMed ID: 15733464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRP receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells.
    Xiao D; Qu X; Weber HC
    Regul Pept; 2002 Nov; 109(1-3):141-8. PubMed ID: 12409226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal.
    Gutiérrez-Cañas I; Rodríguez-Henche N; Bolaños O; Carmena MJ; Prieto JC; Juarranz MG
    Br J Pharmacol; 2003 Jul; 139(5):1050-8. PubMed ID: 12839880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human prostatic carcinoma cell line LNCaP and its derivatives. An overview.
    van Steenbrugge GJ; Groen M; van Dongen JW; Bolt J; van der Korput H; Trapman J; Hasenson M; Horoszewicz J
    Urol Res; 1989; 17(2):71-7. PubMed ID: 2660395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.